English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/14957
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

DC FieldValueLanguage
dc.contributor.authorMarcos López, José Francisco-
dc.contributor.authorGandía Gómez, Mónica-
dc.date.accessioned2009-07-15T11:58:42Z-
dc.date.available2009-07-15T11:58:42Z-
dc.date.issued2009-06-
dc.identifier.citationExpert Opinion on Drug Discovery 4(6): 659-671 (2009)en_US
dc.identifier.issn1746-0441-
dc.identifier.urihttp://hdl.handle.net/10261/14957-
dc.description13 pages, 1 figures, 2 tables.en_US
dc.description.abstract[Background] Antimicrobial peptides (AMP) are widely recognized as promising alternatives to the current use of antibiotics and fungicides. Amino acid sequences of a vast majority of AMP share cationic and amphipathic biophysical properties that allow their insertion into lipid bilayers, and can lead to alteration of biological membrane functions. Initial characterization studies linked these properties to antimicrobial killing activity. However, additional data indicate that this is not the sole mode of action and that more subtle mechanisms might mediate the interaction with and effect to target microbes, as well as the specificity and toxicity of peptides. As such, antimicrobial peptides are increasingly viewed as powerful multifunctional drugs.en_US
dc.description.abstract[Objective] This review will summarize findings on these alternative non-lytic modes of antimicrobial action that go beyond membrane disruption, with an emphasis on the specific interaction with microbial cell wall/membrane components, signaling of AMP exposure, and intracellular targets of peptide characterize and exploit these antimicrobial properties.en_US
dc.description.abstract[Conclusion] Detailed knowledge on non-lytic modes of action of antimicrobial peptides will help in the design and discovery of novel antibacterial and antifungal compounds.en_US
dc.description.sponsorshipOur work on antimicrobial peptides has been supported by grants BIO2003-00927 and BIO2006-09523 (Spain). M.G. is recipient of a research contract from the JAE-DOC Program (CSIC, Spain).en_US
dc.format.extent7521 bytes-
dc.format.mimetypeapplication/pdf-
dc.language.isoengen_US
dc.publisherTaylor & Francisen_US
dc.rightsopenAccessen_US
dc.subjectAntibacterial peptideen_US
dc.subjectAntifungal peptideen_US
dc.subjectAntimicrobial mechanismen_US
dc.subjectApoptosisen_US
dc.subjectCell-penetrating peptidesen_US
dc.subjectChaperoneen_US
dc.subjectGlycanen_US
dc.subjectMAPK signalingen_US
dc.subjectMembrane permeationen_US
dc.subjectTwo-component systemen_US
dc.titleAntimicrobial peptides: To membranes and beyonden_US
dc.typeartículoen_US
dc.identifier.doi10.1517/17460440902992888-
dc.description.peerreviewedPeer revieweden_US
dc.relation.publisherversionhttp://dx.doi.org/10.1517/17460440902992888en_US
Appears in Collections:(IATA) Artículos
Files in This Item:
File Description SizeFormat 
Antimicrobial peptides To membranes and beyond.pdf225,56 kBAdobe PDFThumbnail
View/Open
Show simple item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.